Design Therapeutics, Inc. (DSGN) Operating cash flow 2020–2025
Design Therapeutics, Inc. (DSGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$54.4MFY2025 · since FY2020: -$8.7M → -$54.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.4M | -26.1% |
| FY2024 | -$43.1M | +26.4% |
| FY2023 | -$58.6M | -14.1% |
| FY2022 | -$51.3M | -74.7% |
| FY2021 | -$29.4M | -238.9% |
| FY2020 | -$8.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DSGN financial trends
DSGN RevenueDSGN Net incomeDSGN Net marginDSGN Gross profitDSGN Gross marginDSGN Operating incomeDSGN Operating marginDSGN Free cash flowDSGN Capital expendituresDSGN Return on equityDSGN Stock buybacksDSGN Dividends paidDSGN Total assetsDSGN Total liabilitiesDSGN Shareholders’ equityDSGN overview →